Next-generation vaccine development
Ziphius Vaccines addresses urgent global public health needs by developing
RNA-based vaccines, providing a more robust immune response than traditional vaccines.
Ziphius' vaccine candidate
December 21, 2020
Promising results have been obtained, driving us forward to prepare for clinical trials
Ziphius uses its proprietary self-amplifying RNA-platform for the development of next-generation vaccines.
We are dedicated to leverage our technology for the prevention of a broad range of infectious diseases.
Find out more...
Ziphius Vaccines is a global biopharmaceutical company that wants to make the difference by accelerating the development of novel therapies.
Whether you are looking for a new challenge, an internship, or your first job,
we are looking forward to connecting with you.
Curious for more? Browse this page to find out about our latest news, including research updates, press releases, and upcoming events.